[1] 陈建国,宋新明. 中国肝癌发病水平的估算及分析. 中国肿瘤. 2005,14(1):28-31.
[2] Poon RT. Prevention of recurrence after resection of hepatocellular carcinoma:A daunting challenge. Hepatology. 2011,54(3):757-759.
[3] Visvader JE,Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer,2008,8(10):755-768.
[4] Kamohara Y,Haraguchi N,Mimori K,et al. The search for cancer stem cells in hepatocellular carcinoma. Surgery,2008,144(2):119-124.
[5] Hodgson GS,Bradley TR. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? Nature,1979,281(5730):381-382.
[6] Ding XW,Wu JH,Jiang CP. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci,2010,86(17-18):631-637.
[7] Monzani E,Facchetti F,Galmozzi E,et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer,2007,43(5):935-946.
[8] Morgan J,Jackson JD,Zheng X,et al. Substrate affinity of photosensitizers derived from chlorophyll-a: The ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy. Mol Pharm,2010,7(5):1789-1804.
[9] Schmeizer E,Wauthier E,Reid LM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells,2006,24(8):1852-1858.
[10] Schmelzer E,Zhang L,Bruce A,et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med,2007,204(8):1973-1987.
[11] Zen Y,Fujii T,Yoshikawa S,et al. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol,2007,170(5):1750-1762. |